Akiram Therapeutics is a Swedish biotechnology company developing targeted molecular radiotherapy for patients with incurable cancer.
Its research is based on discoveries made at Uppsala University, and its team has expertise in radiation sciences, cancer precision medicine, and drug development. The company describes its treatment approach as personalized to each patient's cancer.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Its product combines a radiation component with a proprietary antibody to deliver radioactivity to cancer cells while minimizing damage to surrounding healthy tissue.
Source: LinkedIn company description · Retrieved October 13, 2026
The company says it uses radiopharmaceuticals and precision medicine to create treatments for people with cancer.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 22, 2026. How the company lists are built. The source retrieval dates show when RevenueBase obtained these records; the source authors’ last update dates are not available. The saved independent fact check and its source evidence were revalidated on October 14, 2026.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.